What’s New in Sprue (near you)

Slides:



Advertisements
Similar presentations
What’s New in Type 2 Diabetes? Lots!
Advertisements

Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
AGVISE Laboratories %Zone or Grid Samples – Northwood laboratory
PRESENTED BY RTN PP PHF RANJAN ALLES
EuroCondens SGB E.
Health Promotion in Fachhochschule Nordhausen. openingdefinitionfacts results 2 health promotion in Fachhochschule Nordhausen lecturer Sheila Fitzgerald.
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 6 Author: Julia Richards and R. Scott Hawley.
Abortion Worldwide: A Decade of Uneven Progress
DIVERSE COMMUNITIES, COMMON CONCERNS: ASSESSING HEALTH CARE QUALITY FOR MINORITY AMERICANS FINDINGS FROM THE COMMONWEALTH FUND 2001 HEALTH CARE QUALITY.
The Commonwealth Fund 1999 International Health Policy Survey of the Elderly in Five Nations Accompanies May/June 2000 Health Affairs article Charts Originally.
AIDS epidemic update Figure AIDS epidemic update Figure 2007 Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa,
NTDB ® Annual Report 2010 © American College of Surgeons All Rights Reserved Worldwide National Trauma Data Bank 2010 Annual Report.
1 Learning for employment vocational education and training policy in Europe in Europe Greece.
AIDS epidemic update Figure AIDS epidemic update Figure 2007 Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa,
CALENDAR.
1 1  1 =.
TB and the Elderly Patient Beth Gadkowski MD MPH MS Assistant Professor Division of Infectious Diseases Eastern Virginia Medical School.
Trend and change analysis in an Australian surveillance system Associate Professor Anne Taylor South Australian Department of Health University of Adelaide.
The health of young Australians developed by The education team
The demography of agricultural supply and demand Natalie Jackson © Professor of Demography Director, Population Studies Centre >> National Institute of.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2012 Summary Slides SUM12_1.ppt.
Break Time Remaining 10:00.
The basics for simulations
PP Test Review Sections 6-1 to 6-6
Actions to promote sustainable gluten free diet Eleftheria Roma Professor of Paediatric Gastroenterology University of Athens.
The “Great Mimic” Disease
Nutritional Status of Older Persons Presenting in a Primary Care Clinic in Nigeria ADEBUSOYE Lawrence University College Hospital Ibadan, Nigeria.
1 2 Teeth and Function 3 Tooth structure 4 Dental Problems.
Definitions: Definitions: Obesity: Body Mass Index (BMI) of 30 or higher. Obesity: Body Mass Index (BMI) of 30 or higher. Body Mass Index (BMI): A measure.
The Impact of Diabetes Mellitus in the United States
1 Lincolnshire Research Observatory Lincolnshire’s Changing Population Components of Change and the Demographic Impact Eleanor.
Copyright © 2012, Elsevier Inc. All rights Reserved. 1 Chapter 7 Modeling Structure with Blocks.
 What is an eating disorder  What are the types of eating disorders  What are the treatment options  What is an RD’s role in eating disorders.
Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.
1 TV Viewing Trends Rivière-du-Loup EM - Diary Updated Spring 2014.
AHS IV Trivia Game McCreary Centre Society
Chris Bonnett, MHSc, PhD (Cand.) H3 Consulting, Guelph Managing Chronic Disease Can it work at work?
Opportunities for Prevention & Intervention in Child Maltreatment Investigations Involving Infants in Ontario Barbara Fallon, PhD Assistant Professor Jennifer.
Adding Up In Chunks.
MaK_Full ahead loaded 1 Alarm Page Directory (F11)
Facebook Pages 101: Your Organization’s Foothold on the Social Web A Volunteer Leader Webinar Sponsored by CACO December 1, 2010 Andrew Gossen, Senior.
© 2013 E 3 Alliance 2013 CENTRAL TEXAS EDUCATION PROFILE Made possible through the investment of the.
TCCI Barometer September “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
When you see… Find the zeros You think….
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE: An Asian Perspective RODY G. SY, M.D., FPCP, FPCC, FACC Professor, Section of Cardiology Dept of Medicine, UP College.
Clinical Trial Results. org Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson’s Disease Renzo Zanettini, M.D.; Angelo Antonini, M.D.;
Center on Knowledge Translation for Disability and Rehabilitation Research Information Retrieval for International Disability and Rehabilitation Research.
Before Between After.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
7/16/08 1 New Mexico’s Indicator-based Information System for Public Health Data (NM-IBIS) Community Health Assessment Training July 16, 2008.
Minnesota Department of Health Tuberculosis Prevention and Control Program (651) Tuberculosis surveillance data for Minnesota are available on.
Understanding relationships between education, health and well-being among young people: what can the HBSC study contribute? Professor Candace Currie HBSC.
Static Equilibrium; Elasticity and Fracture
Essential Cell Biology
Clock will move after 1 minute
PSSA Preparation.
Essential Cell Biology
DIABETES AND THE EYE: WHAT YOU SHOULD KNOW ABOUT IT
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
Energy Generation in Mitochondria and Chlorplasts
UNDERSTANDING THE ISSUES. 22 HILLSBOROUGH IS A REALLY BIG COUNTY.
Patient Survey Results 2013 Nicki Mott. Patient Survey 2013 Patient Survey conducted by IPOS Mori by posting questionnaires to random patients in the.
1 Dr. Scott Schaefer Least Squares Curves, Rational Representations, Splines and Continuity.
Rhode Island’s Health ─ 2012 Michael Fine, MD Director of Health.
1 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300.
SCREENING FOR CELIAC DISEASE IN EGYPTIAN CHILDREN SCREENING FOR CELIAC DISEASE IN EGYPTIAN CHILDREN Prof. Dr: Mona Abu Zekry -Professor of Pediatrics Head.
Presentation transcript:

What’s New in Sprue (near you) Ciarán P. Kelly, MD Professor of Medicine Harvard Medical School & Director, Celiac Center BIDMC, Boston

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)? News from BIDMC Celiac Center Making gluten challenge less challenging The burden of treating celiac disease - a difficult pill to swallow Progress toward new treatments for celiac disease Getting fat gluten free & why it’s good to have celiac disease CeliacNow.org – Celiac disease & the GFD in digestible bytes More Celiacologists come to Boston

The World View of Celiac Disease 1989 Ireland 1/300 Europe 1/1000 North America CD Rare 1/5000 South America Africa Asia CD Rare

TTG serology enables increased celiac disease diagnosis PCPs “discover” TTG blood test (Tissue TransGlutaminase) What happened here? Garud et al. Aliment Pharmacol Ther 2009;29(8):898-905.

Where is celiac disease most common? 1980’s - Galway Ireland The “capital of celiac disease” Estimated 1 in 303 in 1980’s 1990’s – United States Estimated 0.02% (1/5000) 2000’s – US & Most of the world Estimated ~1% Finland 2000 1% (half diagnosed) 2010 2% (quarter diagnosed)

Common & Not Limited to Europeans Today’s World View of Celiac Disease Finland: ~2.5% North America & Europe 0.6 to 2.5% Northern India ?3% SouthEast Asia CD Rare Subsaharan Africa CD Rare

An expanded perspective Celiac disease An expanded perspective Who? Common in many ethnic backgrounds When? Any age after gluten ingestion Average age at diagnosis ~45 yrs How? Highly diverse presentations. Average 11 years of symptoms prior to diagnosis Celiac Disease Foundation Green AJG 2001, Cranney DDS 2007

Celiac disease now more common in the US? Or just more commonly diagnosed? Then: 9,133 healthy young adults at Warren Air Force Base 1950: Blood collected (1948 to 1954) 0.2% with CD (positive TTG) Now: 12,768 gender-matched subjects from 2 recent US cohorts Circa 2000: Similar years of birth (n = 5558) Similar age at sampling (n = 7210) 0.9% with CD [x 4.5; P < .001]. Mortality hazard ratio = 3.9 (95% CI, 2.0-7.5; P < .001) Conclusions: Celiac disease 4 times more common now than 50 years ago 4 fold increased risk of death with undiagnosed CD over 50 year time period Rubio-Tapia A et al. Gastroenterol 2009;137:88-93. Lohi S et al. Aliment Pharmacol Ther 2007;26:1217-25

Rising incidence of auto-immune & allergic conditions CD in Finland United States Type I Diabetes Bach JF, NEJM 2002, Lohi et al. APT 2007, Rubio-Tapia Gastro 2009

Why is celiac disease more common? “An idle immune system is the devil’s playground” Why are many “auto-immune” and allergic conditions increasingly common? Hygiene theory Our immune system developed to constantly fight germs and parasites Modern hygiene leads it to react against harmless environmental antigens and auto-antigens

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)?

Intestinal damage in Celiac disease & healing on the Gluten Free Diet Flat Villi Healthy Villi

Neither can tolerate it Small bowel biopsies Which person can’t eat gluten? Normal Villous atrophy Neither can tolerate it Slide Atlas of Gastronterology, Misiewicz et al, 1984

Non-Celiac Gluten Sensitivity Theories: Imaginary? Psycho-somatic? Irritable bowel syndrome variant? A result of gluten’s: Indigestibility Ability to activate “innate” immunity versus activation of adaptive immunity in celiac disease INSERT your pet theory HERE

Non-celiac gluten sensitivity Similar & significant differences for: Abdominal pain, bloating, tiredness & satisfaction with stool consistency NCGS is a real phenomenon Celiac disease cannot be diagnosed by a GFD trial

Gluten & wheat associated disorders Celiac disease Non-celiac Gluten Sensitivity Wheat allergy ~1% of population > 1% < 1% Positive IgA tTG antibody test Abnormal biopsy Symptoms on gluten exposure [after allergy and celiac disease excluded] History (food diary) Skin / RAST

Celiac disease versus NCGS (Non-celiac gluten sensitivity) Gluten in diet causes: Symptoms Intestinal injury High celiac antibodies Malabsorbtion & Nutritional deficiencies Complications Osteoporosis, malignancy Genetic predisposition Associated with other auto-immune disorders Requires lifelong, strict GFD Gluten in diet causes: Symptoms No known genetic predisposition No known complications Strictness & duration of GFD may vary

Non-celiac Gluten Sensitivity: The new kid taking over the block? Pros for GFD: More awareness. Easier access. Lower costs? Cons for GFD: Inconsistencies regarding strictness New Yorker cartoon by GREGORY

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)? News from BIDMC Celiac Center Making gluten challenge less challenging

aka Gluten free diet holiday: Already on a Gluten Free Diet but no formal diagnosis Do I have celiac disease (or NCGS)? Gluten challenge: Typical regimen: Full gluten diet for 8 weeks Small intestinal biopsy & celiac antibody tests Why bother? Certainty re diagnosis Celiac disease versus non-celiac gluten sensitivity Certainty re need for lifelong, strict GFD Certainty re family risk Certainty re potential for celiac complications & associations Can “cure” celiac disease! aka Gluten free diet holiday: V

BIDMC Celiac center Gluten challenge study Thank You! BIDMC Celiac center Gluten challenge study Villous height falls on gluten exposure - but 3 g/day = 10 g/day

Gluten challenge: making it easier Improvements: Genetic test before challenge – if negative no challenge Lower dose of gluten (3g versus 10-15g) Option for 2 week dropout (>90% accuracy) Late blood work to increase sensitivity further Next steps? Gluten challenge of biopsy Gluten reaction “biomarkers” in blood 1. 3. 2. 4. 2013 American College of Gastroenterology Guidelines for Gluten Challenge in Celiac disease diagnosis (Am J Gastro in press)

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)? News from BIDMC Celiac Center Making gluten challenge less challenging The burden of treating celiac disease - a difficult pill to swallow

Is There a Role for Non-Dietary Celiac Disease Treatment? Controversial in the past Now widely accepted Better medical & scientific data A more diverse celiac population From expert opinion to opinion of those actually on GFD 42% 35% 23% Satisfaction with GFD Sanders JGLD 2011

Why do we need non-dietary treatments for Celiac Disease? The GFD is highly effective in celiac disease BUT: > 10% Non-responsive to GFD 1 - 2% Refractory to GFD ~ 30% of adults on GFD for celiac disease have ongoing partial villous atrophy on biopsy Strict GFD difficult to maintain At social events For food prepared outside the home When travelling In restaurants & cafeterias Take-out For the elderly For the illiterate For those with mental or psychological impairment Sanders JGLD 2011

† VAS: 0 = Worst imaginable health 100 = Best imaginable health Perceived overall health is excellent in treated Celiac Disease Overall Health Visual Analog Scale VAS † Best @ 78: CD = Celiac disease Worst @ 55.4 ESRD = Renal disease on hemodialysis 78 72.4 76.7 71.6 69.9 70.5 57.8* 55.4* CD 78 (16.7) (61.3-94.7) GERD 71.6 (21.6) (50-93.2) HTN 72.4 (20.9) (51.5-93.3) IBD 76.7 (19.1) (57.6-95.8) CHF 57.8 (21.2)(36.6-79) IBS 70.5 (18.1)(52.4-88.6) DM 69.9 (23)(46.9-92.9) ESRD 55.4 (17.8) (37.6-73.2) † VAS: 0 = Worst imaginable health 100 = Best imaginable health *Compared with CD, p<0.001 BIDMC Celiac Center 2013 – under review 26

† VAS: 0 = Very Easy 100 = Very Difficult Perceived treatment burden of GFD is very high Treatment Burden VAS † Renal disease on Hemodialysis = 56.4 Celiac disease = 44.9 Higher than: Insulin dependant diabetes Irritable bowel syndrome Congestive heart failure Inflammatory bowel disease Hypertension GERD 56.4 44.9 41.7 38.4 40.4 CD 44.9(30.9) Gerd 21.3(25.3) Htn 23.5(25.7) IBD 31.9(27.7) Chf 38.4(31) Ibs 40.4(24.4) Dm 41.7(30.4) Esrd 56.4(31.9) 31.9 23.5* 21.3* † VAS: 0 = Very Easy 100 = Very Difficult *Compared with CD, p<0.001 BIDMC Celiac Center 2013 – under review 27

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)? News from BIDMC Celiac Center Making gluten challenge less challenging The burden of treating celiac disease - a difficult pill to swallow Progress toward new treatments for celiac disease

Help on it’s way? Gluten is Everywhere “Wheat-free” ≠ “Gluten-free.” Dressing Flour or cereal products Gravies Imitation bacon Imitation seafood Lipstick and lip balm Breading Broth/Bouillon Candy Coating/Drink mixes Communion wafers Croutons Marinades Panko Pastas Play-Doh Processed luncheon meats Sauces Dry pet food Seasonings Self-basting poultry Soup bases Thickeners (Roux) Toothpaste Dental pumice Medications Help on it’s way? © 2008 Delete the Wheat

Larazotide acetate reduces symptoms during gluten challenge 86 study subjects Gluten-Related Adverse Events Placebo No challenge Larazotide + Challenge + Challenge Changes in symptom score during gluten challenge Placebo Larazotide No gluten challenge Leffler et al Am J Gastro. 2012;107:1554-62.

Larazotide acetate prevents IgA tTG Increases during gluten challenge Next study completed enrollment >200 subjects Continued symptoms & high tTG Despite GFD IgA-tTG (IgA-tissue Transglutaminase) fold change from baseline (mean) 38 32 25 18 12 6 Gluten challenge Placebo Larazotide acetete: 8 mg three times daily 1 mg three times daily 4 mg three times daily 0.03 0.01 0.02 0.009 0.008 0.005 Day 0 7 21 35 49 56 Last visit Day 0 Day 7 Day 21 Day 35 Day 49 Day 56 LDBTPV 184 study subjects Kelly et al Aliment Pharmacol Ther. 2013 Jan;37(2):252-262.

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)? News from BIDMC Celiac Center Making gluten challenge less challenging The burden of treating celiac disease - a difficult pill to swallow Progress toward new treatments for celiac disease Getting fatter gluten free & why it’s good to have celiac disease

Mean BMI increased from 24.0 to 24.6 In 679 celiac patients: At diagnosis: 32% overweight or obese (compared to 59% in regional population) On GFD: Mean BMI increased from 24.0 to 24.6 22% with normal or high BMI at diagnosis increased BMI by >2 points 15.8% became overweight 22% overweight at diagnosis gained additional weight Attention to weight maintenance essential on GFD Aliment Pharmacol Ther. 2012 Mar;35(6):723-9.

Diabetes Mellitus Type 2 is far less common in Celiac disease Pravelence of diabetes type 2 Celiac - 3.1% Control – 9.6% (x3 celiac rate) Population - 9.8% (x3 celiac rate) P < 0.0001 (n = 840) (n = 840) BMI (Body Mass Index)

What’s New in Sprue International Celiac News How common is celiac disease? A moving target Why are so many people eating Gluten Free (and does it help me)? News from BIDMC Celiac Center Making gluten challenge less challenging The burden of treating celiac disease - a difficult pill to swallow Progress toward new treatments for celiac disease Getting fat gluten free & why it’s good to have celiac disease CeliacNow.org – Celiac disease & the GFD in digestible bytes More Celiacologists come to Boston

What’s New in Sprue (near you)

Celiac disease prevalence - a moving target CeliacNow.org Level 1 – The basics Level 2 – More detailed Level 3 – In depth information

Celiac Research Groups in Boston Boston Children’s Hospital – Director: Alan Leichtner, MD BIDMC – Director: Ciaran Kelly, MD & the new kids on the block: MGH – Director: Alessio Fasano, MD All Major Teaching Hospitals of Harvard Medical School Collaborate in: Research – Education – Fund raising – Combined Groups: ~ 40 Celiac Researchers (MD, PhD, RD et al) > 25 Celiac disease research publications in 2012 Current expenses ~$3 million per annum

What did he say? International Celiac News Celiac disease is more common than ever Non Celiac Gluten Sensitivity - a recognized medical entity News from BIDMC Celiac Center Gluten challenge (aka “GFD holiday”) less challenging GFD considered burdensome by patients New treatments for celiac disease – progress, but slow GFD can make you look fat but at least you may avoid diabetes CeliacNow.org for all your Gluten Free bytes Boston abounds in Celiac Researchers – let’s keep us busy!